AC
XRAY icon

Avestar Capital’s Dentsply Sirona XRAY Stock Holding History

Avestar Capital’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,836
Closed -$223K – 514
2021
Q3 		$223K Buy
3,836
+467
+14% +$28.8K 0.03% 412
2021
Q2 		$213K Sell
3,369
-1,468
-30% -$96.7K 0.03% 414
2021
Q1 		$318K Buy
4,837
+229
+5% +$13.3K 0.07% 236
2020
Q4 		$242K Sell
4,608
-99
-2% -$4.88K 0.07% 241
2020
Q3 		$224K Buy
+4,707
New +$208K 0.07% 200
2019
Q3 		– Sell
-31
Closed – – 864
2019
Q2 		$0 Hold
31
– – ﹤0.01% 990
2019
Q1 		$0 Hold
31
– – ﹤0.01% 992
2018
Q4 		$0 Sell
31
-1,014
-97% -$36.9K ﹤0.01% 1021
2018
Q3 		$5K Sell
1,045
-801
-43% -$33.4K ﹤0.01% 555
2018
Q2 		$61K Buy
1,846
+308
+20% +$14.5K 0.04% 256
2018
Q1 		$55K Buy
1,538
+284
+23% +$16.7K 0.04% 239
2017
Q4 		$69K Buy
+1,254
New +$79.7K 0.05% 204

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Avestar Capital's XRAY Position: Q4 2021 in Review

Avestar Capital sold out of Dentsply Sirona (XRAY) in Q4 2021, closing a stake of 3,836 shares — an estimated $223K sold.

Avestar Capital first reported a position in XRAY in Q4 2017 and held it in 12 quarters. The position peaked at $318K in Q1 2021. 542 funds tracked by Wall St. Rank hold XRAY as of Q4 2021.

  • Avestar Capital reported no remaining Dentsply Sirona position as of Q4 2021 after selling out during the quarter.
  • Avestar Capital sold 3,836 Dentsply Sirona shares in Q4 2021, an estimated $223K.
  • Avestar Capital first reported a position in Dentsply Sirona in Q4 2017 and held it in 12 quarters.
  • Avestar Capital's Dentsply Sirona position peaked at $318K in Q1 2021.
  • 542 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2021.

Based on Avestar Capital's 13F filing for Q4 2021, filed 1 Feb 2022.